Pendred Syndrome in the Czech Republic
Authors:
R. Katra 1; R. Pourová 4,5; P. Dytrych 1; H. Jelínková 3; Z. Kabelka 1; M. Dvořáková 6; J. Astl 2
Authors‘ workplace:
Klinika zobrazovacích metod 2. LF UK a FN Motol, Praha
; DNA laboratoř Kliniky dětské neurologie, UK 2. LF a FN Motol, Praha
; Ústav biologie a lékařské genetiky, UK 2. LF a FN Motol
; Klinika otorinolaryngologie a chirurgie hlavy a krku
Pardubická krajská nemocnice, a. s.
; Klinika ORL a chirurgie hlavy a krku 1. LF UK a FN Motol, Praha
Katedra otorinolaryngologie IPVZ, Praha
; Klinika ušní, nosní a krční 2. LF UK a FN Motol, Praha
Subkatedra dětské otorinolaryngologie IPVZ, Praha
; přednosta doc. MUDr. Z. Kabelka, Ph. D.
1; přednosta prof. MUDr. J. Betka, DrSc.
2; přednosta MUDr. J. Mejzlík, Ph. D.
3; přednosta prof. MUDr. M. Macek, DrSc.
4; přednosta prof. MUDr. V. Komárek, CSc.
5; přednosta doc. MUDr. M. Roček, CSc.
6
Published in:
Otorinolaryngol Foniatr, 60, 2011, No. 2, pp. 103-111.
Category:
Review Article
Overview
Pendred syndrome (PS, OMIM #274600) is an autosomal recessive genetic disease, which becomes manifest in a combination of sensoric-neural deafness and dyshormonogenetic goitre. In the PS we frequently encounter abnormal formation of inner ear structures – enlarged vestibular aqueduct (EVA) and/or Mondini dysplasia (MD). PS is caused by mutations in the SLC26A4 gene (called also PDS gene, OMIM *605646), which encodes the anion transporter pendrin, expressed especially in thyroid gland and the inner ear. Pendrin in the thyroid gland is localized on the apical pole of thyreocytes. Its main function is the transport of iodine into colloids in follicle lumen, where it is subsequently bound to organic molecules. The affection of thyroid gland in the Pendred syndrome becomes manifest mostly in the second decade of life under the picture of euthyroid and hypothyroid goitre, rarely there is dyshormogenesis at birth and the disease is then diagnosed in the newborn screening for congenital hypothyreosis. The mutation in the SLC26A4 gene causes also a non-syndrome hearing loss associated with EVA (formerly called DFNB4, OMIM #600791). Only recently the digenetic heredity has been established – mutation in the SLC26A4 gene in combination with a mutation in the FOXI1 gene (OMIM *601093) or KCNJ10 gene (OMIM *602208).
PS represents the most frequent syndrome deafness and the SLC26A4 gene is apparently the second most frequent gene responsible for AR non-syndrome hearing loss (after GJB2 gene for Connexin 26, which is responsible for 40% of AR non-syndrome hearing loss). A recently undertake study in the Czech Republic confirmed mutation in the SLC26A4 gene in 8.5% of predominantly child patients with inborn hearing loss; however only less than 27% of these children displayed a completely expressed PS (after puberty in all of them). Thanks to molecular genetic examination it is therefore possible to predict with high probability the development of thyroid gland disorder and to prevent the development of goitre by an early intervention. The examination of the SLC26A4 gene in presently available in the Czech Republic.
Key words:
Pendred syndrome, EVA syndrome, Mondini dysplasia, dyshormonogenesis, goitre, SLC26A4gene, PDS.
Sources
1. Abs, R., Verhelst, J., Schoofs, E. et al.: Hyperfunctioning metastatic follicular thyroid carcinoma in Pendred’s syndrome. Cancer, 67, 1991, s. 2191-2193.
2. Al Taji, E., Biebermann, H., Limanova, Z. et al.: Screening for mutations in transcription factors in a Czech cohort of 170 patients with congenital and early-onset hypothyroidism: identification of a novel PAX8 mutation in dominantly inherited early-onset non-autoimmune hypothyroidism. Eur. J. Endocrinol., 156, 2007, s. 521-529.
3. Albert, S., Blons, H., Jonard, L. et al.: SLC26A4 gene is frequently involved in nonsyndromic hearing impairment with enlarged vestibular aqueduct in Caucasian populations. Eur. J. Hum. Genet., 14, 2006, s. 773-779.
4. Arnos, K. S., Cunningham, M., Israel, J. et al.: Innovative approach to genetic counseling services for the deaf population. Am. J. Med. Genet., 44, 1992, s. 345-351.
6. Astl, J.: Chirurgická léčba štítné žlázy. Maxdorf Jessenius, 2007, s. 42-47.
7. Astl, J., Betka, J., Slavíček, A.: Heterotopics thyroid tissue. Head and Neck Diseases, 2, 1993, s. 55-57.
8. Astl, J., Štolbová, D., Skřivan, J.: Struma spojená s nedoslýchavostí. Otorinolaryngologie a foniatrie, 45, 1996, s. 31-34.
9. Astl, J., Veselý, D., Jablonický, P.: Pendredův syndrom - poznámky k problematice vrozené autosomálně recesivní percepční nedoslýchavosti spojené se strumou. Otorinolaryngologie a foniatrie, 53, 2004, s. 55-59.
10. Baldwin, C. T., Weiss, S., Farrer, L. A. et al.: Linkage of congenital, recessive deafness (DFNB4) to chromosome 7q31 and evidence for genetic heterogeneity in the Middle Eastern Druze population. Hum. Mol. Genet., 4, 1995, s. 1637-1642.
11. Banghova, K., Al Taji, E., Cinek, O. et al.: Pendred syndrome among patients with congenital hypothyroidism detected by neonatal screening: identification of two novel PDS/SLC26A4 mutations. Eur. J. Pediatr., 167, 2008, s. 777-783.
12. Bidart, J. M., Lacroix, L., Evain-Brion, D. et al.: Expression of Na+/I- symporter and Pendred syndrome genes in trophoblast cells. J. Clin. Endocrinol. Metab., 85, 2000, s. 4367-4372.
13. Caksen, H., Kurtoglu, S., Yuksel, S. et al.: Do not overlook Pendred’s syndrome in children with sensorineural hearing loss. Ear Nose Throat. J., 80, 2001, s. 760.
14. Colvin, I. B., Beale, T., Harrop-Griffiths, K.: Long-term follow-up of hearing loss in children and young adults with enlarged vestibular aqueducts: relationship to radiologic findings and Pendred syndrome diagnosis. Laryngoscope, 116, 2006, s. 2027-2036.
15. Elamin, A.: Goitre and deaf-mutism. Ups. J. Med. Sci., 96, 1991, s. 213-218.
16. Everett, L. A., Glaser, B., Beck, J. C., et al.: Pendred syndrome is caused by mutations in a putative sulphate transporter gene (PDS). Nat. Genet., 17, 1997, s. 411-422.
17. Fraser, G. R.: Association of congenital deafness with goitre (Pendred’s syndrome) a study of 207 families. Ann. Hum. Genet., 28, 1965, s. 201-249.
18. Fugazzola, L., Mannavola, D., Cerutti, N. et al.: Molecular analysis of the Pendred’s syndrome gene and magnetic resonance imaging studies of the inner ear are essential for the diagnosis of true Pendred’s syndrome. J. Clin. Endocrinol. Metab., 85, 2000, s. 2469-2475.
19. Gaudino, R., Garel, C., Czernichow, P. et al.: Proportion of various types of thyroid disorders among newborns with congenital hypothyroidism and normally located gland: a regional cohort study. Clin. Endocrinol. (Oxf.), 62, 2005, s. 444-448.
20. Goldfeld, M., Glaser, B., Nassir, E. et al.: CT of the ear in Pendred syndrome. Radiology, 235, 2005, s. 537-540.
21. Gorlin, R. J.: Genetic hearing loss associated with endocrine and metabolic disorders. In: Gorlin R. J., Torielle, H. V., Cohen, M. M. Jr. (eds) Hereditary hearing loss and its syndromes. Oxford Monographs on Medical Genetics, 28, Oxford University Press, New York, 1995.
22. Grimaldi, R., Capuano, P., Miranda, N. et al.: Pendrin: physiology, molecular biology and clinical importance. G. Ital. Nefrol., 24, 2007, s. 288-294.
23. Gross, M., Hahn, K., Biesalski, H. K.: The diagnosis of the Pendred syndrome in children by the perchlorate discharge test with 123I (author’s transl). Hno, 29, 1981, s. 95-97.
24. Hníková, O.: Kongenitální hypotyreóza. Pediatrie pro praxi, 3, 2005, s. 123-126.
25. Chen, A. H., Mueller, R. F., Prasad, S. D. et al.: Presymptomatic diagnosis of nonsyndromic hearing loss by genotyping. Arch. Otolaryngol. Head Neck Surg., 124, 1998, s. 20-24.
26. Johnsen, T., Jorgensen, M. B., Johnsen, S.: Mondini cochlea in Pendred’s syndrome. A histological study. Acta Otolaryngol., 102, 1986, s. 239-247.
27. Kabakkaya, Y., Bakan, E., Yigitoglu, M. R. et al.: Pendred’s syndrome. Ann. Otol. Rhinol. Laryngál., 102, 1993, s. 285-288.
28. Kopp, P., Pesce, L., Solis, S. J.: Pendred syndrome and iodide transport in the thyroid. Trends Endocrinol. Metab., 19, 2008, s. 260-268.
29. Laboratory, M. O. R., Clinics, U. O. I. H. A., Department of Otolaryngology - Head and Neck Surgery, P. B. H., Http://Www.Healthcare.Uiowa.Edu/Labs/Pendredandbor/Slcmutations.Htm.
30. Lacroix, L., Mian, C., Caillou, B. et al.: Na(+)/I(-) symporter and Pendred syndrome gene and protein expressions in human extra-thyroidal tissues. Eur. J. Endocrinol., 144, 2001, s. 297-302.
31. Lacroix, L., Michiels, S., Mian, C. et al.: HEX, PAX-8 and TTF-1 gene expression in human thyroid tissues: a comparative analysis with other genes involved in iodide metabolism. Clin. Endocrinol. (Oxf.), 64, 2006, s. 398-404.
32. Li, X. C., Everett, L. A., Lalwani, A. K. et al.: A mutation in PDS causes non-syndromic recessive deafness. Nat. Genet., 18, 1998, s. 215-217.
33. Maciaszczyk, K., Lewinski, A.: Phenotypes of SLC26A4 gene mutations: Pendred syndrome and hypoacusis with enlarged vestibular aqueduct. Neuro Endocrinol. Lett., 29, 2008, s. 29-36.
34. Newton, V. E.: Aetiology of bilateral sensori-neural hearing loss in young children. J. Laryngál. Otol. Suppl., 10, 1985, s. 1-57.
35. Park, S. M., Chatterjee, V. K.: Genetics of congenital hypothyroidism. J. Med. Genet., 42, 2005, s. 379-389.
36. Pearce, J. M.: Pendred’s syndrome. Eur. Neurol., 58, 2007, s. 189-190.
37. Penderd, V.: Deaf-mutism and goitre. Lancet., 2, 1896, s. 532.
38. Phelps, P. D., Coffey, R. A., Trembath, R. C. et al.: Radiological malformations of the ear in Pendred syndrome. Clin. Radiol., 53, 1998, s. 268-273.
39. Pourova, R., Janousek, P., Jurovcik, M. et al.: Spectrum and frequency of SLC26A4 mutations among Czech patients with early hearing loss with and without Enlarged Vestibular Aqueduct (EVA). Ann. Hum. Genet., 74, 2010, s. 299-307.
40. Reardon, W., Coffey, R., Chowdhury, T. et al.: Prevalence, age of onset, and natural history of thyroid disease in Pendred syndrome. J. Med. Genet., 36, 1999, s. 595-598.
41. Reardon, W., Coffey, R., Phelps, P. D. et al.: Pendred syndrome—100 years of underascertainment? Qjm, 90, 1997, s. 443-447.
42. Rillema, J. A., Hill, M. A.: Pendrin transporter carries out iodide uptake into MCF-7 human mammary cancer cells. Exp. Biol. Med. (Maywood), 228, 2003, s. 1078-1082.
43. Rodriguez-Paris, J., Pique, L., Colen, T. et al.: Genotyping with a 198 mutation arrayed primer extension array for hereditary hearing loss: assessment of its diagnostic value for medical practice. PLoS One, 5, 2010, s. e11804.
44. Russo, D., Bulotta, S., Bruno, R. et al.: Sodium/iodide symporter (NIS) and pendrin are expressed differently in hot and cold nodules of thyroid toxic multinodular goiter. Eur. J. Endocrinol., 145, 2001, s. 591-597.
45. Scinicariello, F., Murray, H. E., Smith, L. et al.: Genetic factors that might lead to different responses in individuals exposed to perchlorate. Environ Health Perspect, 113, 2005, s. 1479-1484.
46. Seeman, P., Malikova, M., Raskova, D. et al.: Spectrum and frequencies of mutations in the GJB2 (Cx26) gene among 156 Czech patients with pre-lingual deafness. Clin. Genet., 66, 2004, s. 152-157.
47. Sharghi, S., Haghpanah, V., Heshmat, R. et al.: Comparison of MRI findings with traditional criteria in diagnosis of Pendred syndrome. Int. J. Audio., 46, 2007, s. 69-74.
48. Schrijver, I.: Hereditary non-syndromic sensorineural hearing loss: transforming silence to sound. J. Mol. Dian., 6, 2004, s. 275-284.
49. Skubis-Zegadlo, J., Nikodemska, A., Przytula, E. et al.: Expression of pendrin in benign and malignant human thyroid tissues. Br. J. Cancer, 93, 2005, s. 144-151.
50. Stinckens, C., Huygen, P. L., Joosten, F. B. et al.: Fluctuant, progressive hearing loss associated with Meniere like vertigo in three patients with the Pendred syndrome. Int. J. Pediatr. Otorhinolaryngol, 61, 2001, s. 207-215.
51. Stinckens, C., Huygen, P. L., Van Camp, G. et al.: Pendred syndrome redefined. Report of a new family with fluctuating and progressive hearing loss. Adv. Otorhinolaryngol, 61, 2002, s. 131-141.
52. Sugiura, M., Sato, E., Nakashima, T. et al.: Long-term follow-up in patients with Pendred syndrome: vestibular, auditory and other phenotypes. Eur. Arch. Otorhinolaryngol, 262, 2005, s. 737-743.
53. Suzuki, K., Yoshida, A., Fukata, S.: Pendred syndrome. Nippon Rinsho, Suppl. 1, 2006, s. 371-373.
54. Štolbová, D., Možný, J., Límanová, Z.: Syndrom familiární hyperthyreosy a kochleární nedoslýchavosti s manifestací v mladém věku. Čs. Otolaryng., 32, 1983, s. 34-39.
55. Taybi, H., Lachmann, A.: Radiology of syndromes, metabolic disoders and sceletal dysplasias. Year Book Medical Publishers., 1990, s. 993.
56. Valvassori, G. E., Clemis, J. D.: Abnormal vestibular aqueduct in cochleovestibular disorders. Adv. Otorhinolaryngol, 24, 1978, s. 100-105.
57. Wetke, R.: Goiter of the tongue base and bilateral perceptive impairment of hearing. Ugeskr Laeger, 151, 1989, s. 2734-2735.
58. Yang, J. J., Tsai, C. C., Hsu, H. M. et al.: Hearing loss associated with enlarged vestibular aqueduct and Mondini dysplasia is caused by splice-site mutation in the PDS gene. Hear Res., 199, 2005, s. 22-30.
Labels
Audiology Paediatric ENT ENT (Otorhinolaryngology)Article was published in
Otorhinolaryngology and Phoniatrics
2011 Issue 2
Most read in this issue
- Changes in Communication are the Biggest Handicap in Patients with Permanent Tracheostomy
- Extraesophageal Reflux Disease – Interdisciplinary Consensus
- Pendred Syndrome in the Czech Republic
- Comparison of Basic Diagnostic Methods (Reflux SymptomIndex, Reflux Finding Score, Therapeutic Trial, pH-metry)